Application 202212
- Type
- NDA
- Sponsor
- CIPLA LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEVIRAPINE | NEVIRAPINE | TABLET, FOR SUSPENSION; ORAL | 50MG | No | No |
| 002 | NEVIRAPINE | NEVIRAPINE | TABLET, FOR SUSPENSION; ORAL | 100MG | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 32207 | ORIG | 2012-05-03 |